International partnerships
Your pharmaceutical partner in Sri Lanka
Registration, importation, medical promotion and island-wide distribution for international pharmaceutical manufacturers — from a diversified healthcare group with its own GMP-certified manufacturing.
- Regulatory affairsNMRA registration handled by our own team
- Medical promotionMedical delegates and sales representatives
- Island-wide distributionAppointed distributors and a licensed fleet
- Group manufacturingGMP-certified manufacturing in Sri Lanka
Customer accounts in all nine provinces, served from our licensed warehouse in Nugegoda.
- 2018Established in Nugegoda, Colombo
- 7Foreign principals, from Germany, India and Pakistan
- 1,800+Customer accounts on our ledger
- 12Critical-care injectables in hospitals island-wide
- 9 of 9Provinces with customer accounts
The partnership case
One company that registers, imports, promotes and delivers
MW Lifesciences is a diversified conglomerate operating in Sri Lanka’s healthcare sector. We represent international manufacturers as their local agent — and back that role with our own regulatory team, field force, distribution network and GMP-certified manufacturing.
What a principal gets
A local authorised agent
Required by the regulator for every foreign manufacturer. We act as agent, importer and distributor under one agreement.
Regulatory affairs in-house
Site approval, sample licences, dossiers, variations and renewals, prepared and followed through by our own team.
A field force already in the market
Medical delegates and sales representatives who call on prescribers, hospitals and pharmacies every working day.
Island-wide distribution
Appointed regional distributors and our own NMRA-licensed delivery fleet, serving customers in all nine provinces.
State and private sector access
A supplier to the Medical Supplies Division, the State Pharmaceuticals Corporation and leading private hospitals.
Manufacturing strength behind the agency
GMP-certified manufacturing in the group: technical depth, quality systems and a long-term stake in the country.
A diversified group
One company that makes, imports, registers and distributes healthcare products
Company snapshot
MW Lifesciences at a glance
- Company
- MW Lifesciences (Private) Limited · Reg. no. PV 129583
- Group
- MW Holdings
- Founded
- 2018, by Mr. Manusha Weeraratne
- Corporate office
- No. 320, T. B. Jayah Mawatha, Colombo 10
- Head office
- No. 155, Old Kottawa Road, Mirihana, Nugegoda
- Licensed
- NMRA GMP · NMRA wholesale licence · ISO 9001:2015 · ISO 22716:2007 · Department of Ayurveda
Memberships
Member of SLPMA and COYLE


Leadership
Led by a pharmaceutical scientist

Manusha Weeraratne
Founder & Managing Director, MW Lifesciences (Pvt) Ltd
Manusha is an entrepreneur and pharmaceutical scientist. He began his career as a pharmaceutical technologist at Morisons PLC in Sri Lanka and trained in formulation science in the United Kingdom, at Intract Pharma and at FabRx, a pioneer of 3D-printed medicines. He founded MW Lifesciences in 2018.
He has led the company from a start-up to a diversified healthcare group that manufactures, imports and distributes, and he oversees its relationships with foreign principals personally. He is also a Director of Euro Pharma (Pvt) Ltd, the group’s joint venture.
Since 2019 he has been a Visiting Lecturer in Pharmaceutics at the University of Colombo, where he is helping to launch the Faculty of Science’s first MSc in Pharmaceutical Sciences. He serves on the Executive Committee of the Chamber of Lankan Entrepreneurs (COYLE), where he chairs the Diplomats and Inbound Delegations Subcommittee, and is an active member of the Sri Lanka Pharmaceutical Manufacturers’ Association.
- 2015Morisons PLCPharmaceutical technologist, Sri Lanka
- 2016Intract PharmaFormulation science, United Kingdom
- 2017FabRxFormulation science, United Kingdom
- 2018MW LifesciencesFounder and Managing Director
- 2019University of ColomboVisiting Lecturer in Pharmaceutics
- 2022Euro PharmaDirector
A message from the Founder
“For an international manufacturer, the choice of local partner is the most important decision in entering Sri Lanka.”
Register properly
Complete dossiers, accurate claims and registrations kept current.
Promote ethically
Scientific detailing to healthcare professionals, within the approved label.
Supply without interruption
Stock planned against demand, delivered through a licensed chain.
Sri Lanka imports most of the medicines its people rely on. Every one of those products reaches patients through a local company that registers it, imports it, explains it to doctors and keeps it on the shelf. I founded MW Lifesciences in 2018 to be that company for manufacturers who care how their brands are represented.
We began as manufacturers. We earned GMP certification from the national regulator, built brands that hospitals across the country now rely on, and supplied more than 2.5 million litres of hand sanitiser to the Government and private hospitals during the pandemic. That discipline — in quality, in regulation and in keeping supply moving — is what we bring to the principals we represent.
Today we act for seven foreign principals from Germany, India and Pakistan. Our regulatory team prepares and follows through every submission. Our medical delegates and sales representatives take each brand to prescribers, hospitals and pharmacies. Our distributors and licensed fleet deliver across the island.
We are deliberately selective. We take on products we can register properly, promote ethically and supply without interruption, and we treat every agency as a long-term commitment rather than a line on a price list.
If Sri Lanka is on your map, I would welcome the opportunity to show you what we can build together.
Manusha Weeraratne
Founder & Managing Director, MW Lifesciences (Pvt) Ltd
Marketing, operations and key accounts
Ajith Rodrigo
General Manager – Marketing & Operations, MW Lifesciences (Pvt) Ltd
PGDip (Mkt), MSLIM
Forty years in pharmaceuticals.
Every key account in his hands.
Ajith began his career at GlaxoSmithKline and has spent four decades in the pharmaceutical industry, with George Steuart Health, ABC Pharma and Pharma Associates along the way.
At MW Lifesciences he leads marketing and operations and handles all of the company’s key accounts, so the customers that matter most to your brand deal directly with a senior leader who knows the industry from the inside. He is a specialist in antibiotic medicines.
- 40 yearsin the pharmaceutical industry
- Key accountsevery one handled by Ajith
- Antibioticshis specialist therapy area
How an agency is staffed. Each principal is given a named commercial lead and a regulatory contact, with the Managing Director as executive sponsor. The group’s research and development team of pharmacists and formulation scientists provides technical support.
A direct line to the decision-maker. Agency discussions, business plans and annual reviews are led by the Managing Director, so principals deal with the person accountable for the result.
The market
Sri Lanka: a market that depends on trusted imports
An island of nearly 22 million people with universal state healthcare, a growing private sector and limited domestic production. Most medicines are imported — and each one enters through a local authorised agent.
The state sector
- Healthcare is free at the point of care in Ministry of Health hospitals.
- Medicines are bought centrally: the State Pharmaceuticals Corporation procures for the Medical Supplies Division, mainly by international competitive bidding.
- Products offered must be registered with the NMRA; bidders are told to have their local representatives attend to it.
The private sector
- Private hospitals, pharmacies and dispensing practitioners are supplied by importers and their distributors.
- Brand choice is driven by the prescriber, so sustained medical promotion decides market share.
- The NMRA sets maximum retail prices, using a formula that starts from the import (CIF) price.
Regulation
- The National Medicines Regulatory Authority (NMRA) regulates medicines, medical devices, borderline products and cosmetics.
- A foreign manufacturer must appoint a Sri Lankan company as its local authorised agent; every application is made through that agent.
- A certificate of registration is normally valid for five years.
What this means for a manufacturer
The local agent is the regulatory applicant, the importer and the face of the brand.
Registration is the gate to both sectors. It depends on the agent’s dossiers and follow-through.
Tenders and prescriptions need different skills. A partner should offer both.
Agencies are tied to registrations for years. Choose a partner invested in the country.
Sources: Department of Census and Statistics, Census of Population and Housing 2024 (21,781,800) · Board of Investment of Sri Lanka (import share and market value) · Sri Lanka Pharmaceutical Manufacturers’ Association (share of demand met by Government procurement and by the private sector) · hospital numbers as reported by AHK Sri Lanka (March 2026), citing the Ministry of Health for public hospitals · National Medicines Regulatory Authority · State Pharmaceuticals Corporation of Sri Lanka. Figures are rounded.
What we do for principals
One accountable partner, from dossier to delivery
A principal’s product has to clear regulation, reach the warehouse, win the prescriber and arrive at the pharmacy. We manage each stage with our own people.
- 1
Market assessment
We screen your portfolio against private-market demand and state procurement data, review pricing and competing registrations, and set out the opportunity in a written business plan.
You getA product-by-product entry plan - 2
Regulatory affairs
As your local authorised agent we obtain manufacturing-site approval and sample licences, compile and submit each dossier, answer the regulator’s queries and keep registrations current.
You getRegistered products, kept compliant - 3
Importation and supply
We obtain import licences, clear each consignment and hold stock in our NMRA-licensed wholesale premises under a responsible pharmacist, planned against forecast demand.
You getContinuous availability - 4
Medical promotion
Our medical delegates detail your brands to consultants, general practitioners and hospital pharmacists, supported by product training, literature and scientific programmes.
You getPrescriber awareness and demand - 5
Sales and distribution
Dedicated hospital and pharmacy sales divisions take orders across the island. Appointed regional distributors and our own NMRA-licensed fleet deliver them.
You getIsland-wide coverage - 6
Institutional and tender business
We represent you in state procurement: monitoring tenders, preparing and submitting bids to the State Pharmaceuticals Corporation and managing supply to the Medical Supplies Division.
You getAccess to the state sector - 7
After-market stewardship
Price compliance, quality complaints, recalls and safety reporting are handled by our regulatory and quality teams, with regular sales and stock reports to you.
You getA protected brand
NMRA registration
Registration, managed in-house
Every medicine sold in Sri Lanka must be registered with the National Medicines Regulatory Authority, and a foreign manufacturer can apply only through a local authorised agent. Our regulatory affairs team takes on that role.
Who acts at each step:YouMW LifesciencesNMRA
- 1
Appointment You
You issue a letter of authorisation naming MW Lifesciences as your local authorised agent in Sri Lanka.
- 2
Manufacturing-site approval MW LifesciencesNMRA
We apply for approval of each manufacturing site, with its site master file and supporting documents. The NMRA reviews the file and may inspect the site.
- 3
Sample import licence MW LifesciencesNMRA
We obtain the licence to import registration samples of each product.
- 4
Marketing authorisation application MW Lifesciences
We compile and submit the product dossier and samples in the format the NMRA requires, including the electronic (eCTD) copy.
- 5
Evaluation NMRAMW Lifesciences
The Medicines Evaluation Committee reviews the application. We answer its queries and supply further data where needed.
- 6
Registration NMRA
The NMRA issues the certificate of registration, valid for five years. A manufacturer new to Sri Lanka may first receive provisional registration for one or two years.
- 7
Import licence and launch MW Lifesciences
We obtain the licence to import the registered medicine, bring in the first consignment and begin promotion.
What we typically need from you
- Letter of authorisation
- Site master file and GMP certificate for each site
- Manufacturing licence
- Certificate of Pharmaceutical Product
- Product dossier, with electronic (eCTD) copy
- Samples and reference standards
- Registration status in other countries
Why our team is equipped
We are regulated ourselves
As a GMP-certified manufacturer we prepare site master files, dossiers, variations and renewals for our own products.
A dedicated division
Regulatory affairs is an in-house function with its own head, staffed by pharmacists and science graduates.
Several authorities
We also work with the Department of Ayurveda and the Veterinary Drug Control Authority.
A shorter path for inspected sites
The NMRA may exempt a manufacturing site from on-site GMP inspection where a reference regulatory authority or the WHO has already inspected it.
Reliance routes
NMRA guidance also provides for reliance on reference regulatory authorities, and for the WHO collaborative procedure for WHO-prequalified products.
Summarised from NMRA guidance on medicines and manufacturing sites. Requirements vary by product category; medical devices, borderline products and cosmetics follow their own NMRA procedures.
Field force
A field force already in front of prescribers
Our medical delegates and sales representatives are in hospitals, clinics and pharmacies every working day. A new brand joins an established call cycle from its first month.
Who the team calls on
Consultants and general practitioners
Detailing and scientific follow-up with the doctors who write the prescription.
Private hospitals and nursing homes
Pharmacy, procurement and clinical departments in the leading hospital groups.
Fertility and specialist clinics
Specialist centres supplied with our injectable range.
Pharmacies and pharmacy chains
More than 200 pharmacies and chemists, including Union Chemists and CFC Healthcare.
State institutions
The Medical Supplies Division, State Pharmaceuticals Corporation and government hospitals.
Corporate and institutional buyers
Companies, banks, hotels and public bodies buying for their own facilities.
What the team does for your brand
- Details your brands to prescribers, using your approved materials
- Trains hospital and pharmacy staff on each product
- Works products onto hospital formularies and purchase lists
- Books and follows up orders through every sales cycle
- Runs launch programmes and scientific meetings with you
- Reports demand, competitor activity and market feedback
Distribution
Distribution across the island
Appointed distributors in the regions and our own licensed fleet carry products from our Nugegoda warehouse to hospitals, pharmacies and clinics in all nine provinces.
Appointed regional distributors
Head office and central warehouse, Nugegoda
An appointed distributor covers every province. Hover over or tap a distributor to see its area on the map.
- Central warehouse, NugegodaNMRA-licensed wholesale premises under a responsible pharmacist (licence WL-04020).
- Our own delivery fleetVehicles licensed by the NMRA for the transport of medicines.
- Appointed regional distributorsLocal stockholding and delivery beyond Colombo.
- Hospitals, pharmacies and clinicsDirect delivery to key accounts and institutions.

Market reach
Inside Sri Lanka’s hospitals, pharmacies and institutions
MW Lifesciences supplies the state health sector and holds accounts with the country’s leading private hospitals, pharmacy and supermarket chains, more than 200 pharmacies and chemists, and many of Sri Lanka’s best-known companies, banks and public bodies.
State health sector
Supplier to the Ministry of Health
We supply the Medical Supplies Division and the State Pharmaceuticals Corporation. During the COVID-19 pandemic we delivered more than 2.5 million litres of MediSafe hand sanitiser to the Government of Sri Lanka and leading private hospitals.
Also supplied: Lady Ridgeway Hospital for Children · Police Hospital, Narahenpita · Sri Lanka Medical Council · Medical Faculty, University of Sri Jayewardenepura



Private hospitals and specialist centres
18 groups shown; branch accounts are grouped








Also suppliedMelsta Hospitals, Ragama · Co-operative Hospital, Galle · Queensbury Hospitals · Royal Hospital · Park Hospital · Western Hospital · Winlanka Hospital · Santa Dora Hospital · Delmon Hospital · Navodaya Hospital · St Joseph Hospital, Negombo · Healthline Medical Diagnostics
Accounts already open
A new product reaches procurement desks that already buy from us. Listing does not begin with vendor registration.
Hospital relationships
Our hospital sales division calls on hospital pharmacies, procurement teams and clinicians.
Both sectors
We supply government institutions through state procurement and private hospitals through direct accounts.
Pharmacy and supermarket chains
Key accounts include Union Chemists and CFC Healthcare

Corporate and institutional customers
A selection from our customer ledger

Basis of preparation: every organisation shown holds a customer account with MW Lifesciences (Pvt) Ltd, as recorded in the company’s customer ledger (October 2026); branch and unit accounts are counted individually. Logos are the trademarks of their respective owners, reproduced for identification only, and do not imply endorsement.
Track record
Proven with principals, hospitals and the local industry
MW Lifesciences is the Sri Lankan agent and distributor for manufacturers in Germany, India and Pakistan, markets a critical-care injectable range in hospitals island-wide, and works with the country’s leading pharmaceutical companies.
Seven foreign principals, three countries
Agent and distributor in Sri Lanka




What we import and distribute
Pharmaceuticals
Finished medicines for hospitals and pharmacies.
Ayurvedic medicines
Classical Ayurvedic preparations imported from Kerala.
Multivitamins and supplements
German vitamin, mineral and consumer-health ranges.
Medical devices
Clinical and therapeutic equipment, consumables and protective wear.
In vitro diagnostic products (IVD)
Reagents and test kits for hospital and clinical laboratories.
International suppliers to our own manufacturing
The group’s factories buy active and functional ingredients from established international suppliers, backed by their efficacy data and tested by our quality teams before use.
What principals rely on us for
Agent, importer and distributor under one agreement
- Registration and regulatory upkeep
- Importation, storage and stock planning
- Promotion to doctors, hospitals and pharmacies
- Island-wide distribution
Twelve critical-care injectables, in hospitals island-wide
Marketed and distributed by MW Lifesciences| Generic name | Dosage form and strength | Therapeutic class |
|---|---|---|
| Anti-infectives | ||
| Meropenem | Injection, 1 g | Carbapenem antibiotic |
| Vancomycin | Injection, 500 mg | Glycopeptide antibiotic |
| Amikacin | Injection, 250 mg and 500 mg | Aminoglycoside antibiotic |
| Oncology support and hormonal therapy | ||
| Filgrastim | Solution for injection, 300 mcg | G-CSF · neutropenia support |
| Leuprolide acetate | Lyophilised injection, 3.75 mg | GnRH agonist · hormonal therapy |
| Anaesthesia, sedation and anticonvulsants | ||
| Ketamine | Injection | General anaesthetic |
| Diazepam | Injection | Benzodiazepine · sedation |
| Phenytoin | Injection | Anticonvulsant |
| Emergency and supportive care | ||
| Tranexamic acid | Injection | Antifibrinolytic · bleeding control |
| Verapamil | Injection | Calcium-channel blocker · arrhythmia |
| Chlorphenamine maleate | Injection | Antihistamine · acute allergy |
| Thiamine | Injection | Vitamin B1 replacement |
Proof of hospital access for injectable principals
This range is ordered, stocked and administered in hospitals across the island today. A manufacturer of hospital injectables gains a sales team that already knows the buyers, the formularies and the clinicians.
Trusted by Sri Lanka’s pharmaceutical industry
As a manufacturer, a marketing partner and a distributor





Manufacturing
Products made in our GMP-certified facility are marketed by established pharmaceutical houses.
Marketing and distribution
We promote and distribute partner ranges, including the critical-care injectable portfolio.
Joint venture
Euro Pharma (Pvt) Ltd is our joint venture with one of Sri Lanka’s largest pharmaceutical distributors.

Sri Lanka Pharmaceutical Manufacturers’ Association
Member of the industry association, which is affiliated to the Ceylon Chamber of Commerce.

Chamber of Lankan Entrepreneurs (COYLE)
Member company. Our Managing Director serves on its Executive Committee.
Project delivery with an international partner
Medical-waste incinerator, Sri Jayewardenepura General Hospital
Installed with the international specialist CHUWASTAR and commissioned in the presence of the Minister of Health.
We build brands in this market — starting with our own
The same disciplines now serve our principals
MediSafe
Pharmaceutical and hospitalTopical and dermatological medicines, antiseptics, disinfectants and the hand-hygiene range used across the country’s hospitals.
VitaDerm
Advanced skincareAnti-ageing, acne-care and brightening ranges backed by clinical-grade actives.
todaycare
Home and personal careEveryday cleaning and hygiene products, including the FURRfresh pet-care line.
VitaPeak
Animal nutritionFeed supplements for poultry, ruminant and swine operations.
Trusted when it mattered most
During the COVID-19 pandemic MediSafe hand sanitiser became a nationally trusted product, supplied to the Government of Sri Lanka and to leading hospitals including Asiri, Lanka Hospitals, Durdans, Ninewells and Sri Jayewardenepura General Hospital.
Launch discipline
Formulation, registration, production and promotion managed by one team.
Hospital adoption
Hand-hygiene and antiseptic products relied on by the country’s leading hospitals.
Retail presence
Consumer lines sold through pharmacies, retail outlets and our own online stores.
The group
Manufacturing strength within a diversified group
MW Lifesciences is a diversified conglomerate. Alongside its agency and distribution business the group manufactures pharmaceutical and healthcare products in Sri Lanka — the technical base behind every product we represent.
What the group manufactures
Category A steroidal products
Steroidal dermatological preparations, produced under controlled conditions.
Category B topical pharmaceuticals
Creams, ointments, gels, lotions and solutions for external use.
Ayurvedic products
Balms, oils and creams registered with the Department of Ayurveda.
Cosmetics
Dermo-cosmetic skincare, sunscreens and personal care.
Veterinary products
Veterinary topicals and the VitaPeak animal-nutrition range.
FMCG cleaning and hygiene
Hand hygiene, disinfectants and todaycare home-care products.
Why this matters to a principal
Manufacturing in the group is a credential, not a conflict.
Regulatory fluency
We answer to the same regulator, inspections and documentation that govern your registration.
Quality discipline
GMP habits carry into how we store, handle and trace the products we import.
Scientific staff
Pharmacists and scientists who can discuss your product with clinicians on its merits.
Committed capital
Plant, people and licences in Sri Lanka. We are here for the long term.
Complementary by design. Our own production is concentrated in topical, Ayurvedic, cosmetic, veterinary and hygiene products. We look for principals whose portfolios extend that range rather than overlap with it.
Euro Pharma
Euro Pharma: the group’s second facility
Euro Pharma (Pvt) Ltd extends the group beyond the Nugegoda plant, adding dosage forms that Sri Lanka has historically imported.

Euro Pharma (Pvt) Ltd- Structure
- Joint venture with one of Sri Lanka’s largest pharmaceutical distributors, established 2022
- Factory
- No. 318/14, Colombo–Horana Road, Kumbuka, Gonapala
- Facility
- Purpose-built plant of about 19,000 sq ft
- Inspection
- NMRA GMP inspection, 28 February 2025, for topical products of Category A and Category B
- Programme
- Commissioning and launch, 2026/2027
- Board
- Mr. Manusha Weeraratne, Director
What the facility is built for
Category A and B topical products
Steroidal creams, ointments and gels for dermatological therapy, alongside Category B preparations. Development and sample batches for approval are covered by the ISO 9001:2015 certificate.
Oral liquids
Syrups, suspensions and solutions for paediatric and general use.
Oral solid dosage
Tablets and other oral solids, completing the group’s range of dosage forms.
Inside the Euro Pharma plant




Mixing, filling and tube-sealing equipment at Euro Pharma (Pvt) Ltd, No. 318/14, Colombo–Horana Road, Kumbuka, Gonapala.
An option for principals
A route to local manufacture
Where a principal’s strategy favours production in Sri Lanka, the group can discuss manufacturing or packing under licence in its facilities, subject to regulatory approval.
When it is worth considering
- Security of supply for high-volume lines
- Shorter lead times and lower landed cost
- Government policy that encourages local production
Licences and certifications
Licensed to register, store and sell medicines
Every business that sells medicines in Sri Lanka must hold a licence from the National Medicines Regulatory Authority (NMRA). MW Lifesciences holds that licence itself, alongside GMP and ISO certification for the group’s manufacturing.
Our NMRA wholesale licence
Current to January 2027- Licence
- Licence to sell therapeutic goods by wholesale
- Number
- WL-04020
- Issued by
- National Medicines Regulatory Authority, Sri Lanka
- Issued under
- Regulation 111(2) of the National Medicines (Registration and Licensing of Medicine) Regulations, 2019, made under the NMRA Act, No. 5 of 2015
- Premises
- M W Lifesciences Warehouse, owned by M W Lifesciences (Private) Limited, No. 155, Old Kottawa Road, Mirihana, Nugegoda
- Function
- Sale of medicine
- Issued
- 10 November 2025
- In force
- 20 January 2026 to 19 January 2027
Select to enlarge. The responsible pharmacist’s photograph is not reproduced.
What the licence enables us to do
Sell medicines by wholesale
Supply medicines in trade quantities to hospitals, pharmacies, clinics and our appointed distributors.
Keep stock for sale
Hold the products we import and represent at premises the NMRA has licensed: our warehouse at Mirihana.
Trade under a responsible pharmacist
A pharmacist registered with the Sri Lanka Medical Council is named on the licence.
Work to the regulator’s conditions
The licence is subject to the conditions prescribed in Regulation 113 of the 2019 Regulations.
Why it matters to a principal
Your agent is also a licensed seller
Under the NMRA Act a medicine may be stored, distributed or sold only by a business licensed for that purpose, and only from licensed premises. MW Lifesciences holds that licence itself, so the agent that registers and imports your product is also licensed to stock it and sell it to the trade.
The NMRA licences behind each delivery
- 1Certificate of registrationeach product
- 2Import licenceeach registered product
- 3Wholesale licence WL-04020our warehouse
- 4Transport licencesour delivery vehicles
Certificates on file
Select any certificate to view itMW Lifesciences (Private) Limited · regulatory licences and good manufacturing practice
MW Lifesciences · ISO 9001:2015 · Control Union
Euro Pharma (Pvt) Ltd · ISO 9001:2015 · Ceycert
Control Union certificates
Validity of the ISO 9001:2015 certificate can be confirmed at www.controlunion.com.
Ceycert certificates
Each certificate carries a QR code linked to the issuer’s database at www.ceycert.com.
Regulator documents
NMRA and Department of Ayurveda documents form part of the due-diligence pack for prospective principals.
Also heldNMRA transport licences for our fleet · Veterinary Drug Control Authority certification · registrations with the Ministries of Industries, Defence and Urban Development · Central Environmental Authority approval · fire certificate.
How quality is assured
Products follow British Pharmacopoeia and United States Pharmacopeia guidelines, and external formulations meet SLS standards. Microbiological, active-ingredient and stability testing goes through the Sri Lanka Pharmaceutical Laboratory of the University of Colombo and the Industrial Technology Institute. Separate quality assurance and quality control functions release each batch.
Due-diligence pack
Copies of every licence and certificate, the site master file and company registration documents are available to prospective principals under a confidentiality agreement.
Working together
Ways to work with us
Most principals appoint us as exclusive agent and distributor for Sri Lanka. Where a manufacturer’s needs are narrower, we structure the arrangement to fit.
Exclusive agency and distribution
Manufacturers entering Sri Lanka, or changing their representation.
We register, import, promote and distribute the portfolio in the private market and represent it in state tenders.
Tender and institutional representation
Manufacturers whose first interest is government procurement.
We register the products, bid for State Pharmaceuticals Corporation tenders and manage supply to the Medical Supplies Division.
Marketing and distribution partnership
Products already registered in Sri Lanka that need stronger promotion or wider reach.
Our field force details and sells the range; our distributors and fleet deliver it.
Medical devices, diagnostics and hospital supplies
Device, diagnostic and consumables manufacturers.
We handle NMRA device registration, importation and sales to hospitals and laboratories.
Local manufacturing under licence
Principals who want production or packing in Sri Lanka.
The group manufactures or packs in its GMP-certified facilities, subject to regulatory approval.
What our agency agreements typically set out
- Territory and exclusivity
- Products covered
- Term and renewal
- Registration responsibilities and costs
- Supply price, currency and payment terms
- Minimum shelf life on delivery
- Promotional support and samples
- Targets, reporting and review
What we ask of our principals
Product, documentation and support
- Consistent quality and reliable supply
- Regulatory documents, samples and answers
- Product training and promotional material
- Competitive pricing, including for tenders
- Exclusivity for the agreed products
What you can expect from us
Registration, reach and accountability
- A written business plan before signature
- All regulatory work, with status reports
- Importation, warehousing and distribution
- Medical promotion and tender bidding
- Regular reporting and strict confidentiality
From first conversation to first shipment
Five steps to market
- 1
Introduction
- Company profiles exchanged
- Confidentiality agreement
- Portfolio and priorities shared
- 2
Assessment
- Product-by-product screening
- Regulatory route and pricing
- Private and state opportunity
- 3
Agreement
- Written business plan
- Agency agreement
- Letter of authorisation
- 4
Registration
- Manufacturing-site approval
- Samples and dossiers
- NMRA evaluation
- 5
Launch and growth
- First consignment
- Training and promotion
- Tenders and regular reviews
Why MW Lifesciences
Eight reasons to place your products with us
- Regulatory affairs in-houseA dedicated team that prepares, submits and maintains every registration.
- A field force already in the marketMedical delegates and sales representatives calling on prescribers, hospitals and pharmacies.
- Licensed distribution to all nine provincesAn NMRA wholesale licence, appointed regional distributors and our own licensed fleet.
- State and private sector accessA supplier to the Ministry of Health and to the leading private hospitals.
- Proven with foreign principalsAgent and distributor for seven principals from Germany, India and Pakistan.
- Trusted by the local industryWorking relationships with Sri Lanka’s leading pharmaceutical companies.
- Manufacturing and scientific depthCertified manufacturing, pharmacists and formulation scientists in the group.
- Founder-led and long-termEvery agency is sponsored by the Managing Director.
The principals we would like to meet
Manufacturers ready to enter Sri Lanka with one committed partner
We are seeking exclusive agency and distribution agreements with manufacturers that are not yet represented in Sri Lanka, or that are reviewing their representation.
Areas of interest
- Prescription and specialty medicines
- Hospital and critical-care injectables
- Oncology, biologics and biosimilars
- Medical devices and diagnostics
- Consumer healthcare and vitamins
Partnership enquiries
Let’s talk about your portfolio in Sri Lanka
Send us your product list and we will respond with an initial view of the regulatory route and the opportunity.
- Contact
- Mr. Manusha WeeraratneFounder & Managing Director
- [email protected]
- Telephone
- +94 701 100 100
- Corporate office
- No. 320, T. B. Jayah Mawatha, Colombo 10Open in Google Maps
- Head office
- No. 155, Old Kottawa Road, Mirihana, NugegodaOpen in Google Maps
- Euro Pharma factory
- No. 318/14, Colombo–Horana Road, Kumbuka, GonapalaOpen in Google Maps
- Brand site
- medisafe.lk
Download the company profile (PDF, 6 MB)
Looking for a job with us? Apply on our careers page.
Salutifer Orbi — bringing health to the world
